Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in MESO — Mesoblast Ltd

CIK 1446194 BALA CYNWYD, PA

Position in MESO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,943,939
-$1,810,446 QoQ
Shares Held
386,472
-10.1% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Derivatives in MESO

reported options exposure · as of Mar 31, 2026
CallValue
$3,497,412
CallShares
227,400
PutValue
$1,548,766
PutShares
100,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. MESO ranks #47 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MESO

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,497,412 227,400
2026-03-31 $1,548,766 100,700
2026-03-31 $5,943,939 386,472
2025-12-31 $9,716,344 538,600
2025-12-31 $1,899,612 105,300
2025-12-31 $7,754,385 429,844
2025-09-30 $3,545,811 220,100
2025-09-30 $4,373,671 271,488
2025-09-30 $1,245,303 77,300
2025-06-30 $1,237,104 113,600
2025-06-30 $2,554,652 234,587
2025-06-30 $1,720,620 158,000
2025-03-31 $3,256,543 260,941
2025-03-31 $1,213,056 97,200
2025-03-31 $3,005,184 240,800
2024-12-31 $5,199,480 262,600
2024-12-31 $3,048,784 153,979
2024-12-31 $2,942,280 148,600
2024-09-30 $953,782 116,742
2024-09-30 $276,146 33,800
2024-09-30 $1,545,764 189,200
2024-06-30 $1,020,138 149,800
2024-06-30 $494,998 72,687
2024-06-30 $435,840 64,000
2024-03-31 $461,922 92,200
2024-03-31 $133,266 26,600
2024-03-31 $288,105 57,506